FDA label
What is Lokelma used for?
Lokelma contains sodium zirconium cyclosilicate. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “LOKELMA is indicated for the treatment of hyperkalemia in adults.”
Run it in Rivvi
Which 2027 plans near you dropped or restricted Lokelma?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Lokelma, powder, for suspension
Indications and Usage, quoted from the label by AstraZeneca Pharmaceuticals LP (NDA207078). Cross-references to other label sections are left out.
LOKELMA is indicated for the treatment of hyperkalemia in adults.
Limitation of Use
LOKELMA should not be used as an emergency treatment for life-threatening hyperkalemia because of its delayed onset of action.
Source: DailyMed label, set id 90bf8e28-748d-4e4b-a19f-9cf483370eff, version 28, effective February 8, 2024. NDC 0310-1105, one of 4 listings for this product.
Questions
What is Lokelma used for?
The FDA label says: “LOKELMA is indicated for the treatment of hyperkalemia in adults.”
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.